TFBS Bioscience (ROCO:6939) Asset Turnover: 0.07 (As of Dec. 2025)


ROCO:6939 TFBS Bioscience Inc ROCO:6939
49 GF Score
Price NT$20.70
GF Value NT$32.15
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is TFBS Bioscience Asset Turnover?

TFBS Bioscience ROCO:6939 49 Asset Turnover is 0.07 as of Dec. 2025. GuruFocus rates ROCO:6939 with a GF Score™ of 49/100 and a GF Value™ of NT$32.15 (Possible Value Trap). The stock has 6 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. TFBS Bioscience's Revenue for the six months ended in Dec. 2025 was NT$106.2 Mil. TFBS Bioscience's Total Assets for the quarter that ended in Dec. 2025 was NT$1,491.3 Mil. Therefore, TFBS Bioscience's Asset Turnover for the quarter that ended in Dec. 2025 was 0.07.

Asset Turnover is linked to ROE % through Du Pont Formula. TFBS Bioscience's annualized ROE % for the quarter that ended in Dec. 2025 was -5.87%. It is also linked to ROA % through Du Pont Formula. TFBS Bioscience's annualized ROA % for the quarter that ended in Dec. 2025 was -4.64%.

TFBS Bioscience  (ROCO:6939) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

TFBS Bioscience's annulized ROE % for the quarter that ended in Dec. 2025 is

ROE %**(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-69.192/1179.5205
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-69.192 / 212.31)*(212.31 / 1491.3415)*(1491.3415/ 1179.5205)
=Net Margin %*Asset Turnover*Equity Multiplier
=-32.59 %*0.1424*1.2644
=ROA %*Equity Multiplier
=-4.64 %*1.2644
=-5.87 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

TFBS Bioscience's annulized ROA % for the quarter that ended in Dec. 2025 is

ROA %(Q: Dec. 2025 )
=Net Income/Total Assets
=-69.192/1491.3415
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-69.192 / 212.31)*(212.31 / 1491.3415)
=Net Margin %*Asset Turnover
=-32.59 %*0.1424
=-4.64 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

TFBS Bioscience Asset Turnover Related Terms

TFBS Bioscience Asset Turnover Historical Data

* Premium members only.

The historical data trend for TFBS Bioscience's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Asset Turnover Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
Get a 7-Day Free Trial 0.41 0.27 0.17 0.12 0.13

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.06 0.06 0.06 0.07

ROCO:6939 vs TMO, DHR, IDXX: Asset Turnover Comparison

For the Diagnostics & Research subindustry, TFBS Bioscience's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TFBS Bioscience Asset Turnover vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's Asset Turnover distribution charts can be found below:

* The bar in red indicates where TFBS Bioscience's Asset Turnover falls into.


ROCO:6939
49GF Score
TFBS Bioscience Inc ROCO:6939
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TFBS Bioscience Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

TFBS Bioscience's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=193.142/( (1497.859+1458.825)/ 2 )
=193.142/1478.342
=0.13

TFBS Bioscience's Asset Turnover for the quarter that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=106.155/( (1523.858+1458.825)/ 2 )
=106.155/1491.3415
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.07 mean?
TFBS Bioscience (ROCO:6939) has a Asset Turnover of 0.07 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on TFBS Bioscience and its competitors.
Is TFBS Bioscience's Asset Turnover too high?
TFBS Bioscience's current Asset Turnover is 0.07. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Asset Turnover compare to TMO and DHR?
TFBS Bioscience's Asset Turnover of 0.07 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Diagnostics & Research company?
A good Asset Turnover depends on the Medical Diagnostics & Research industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on TFBS Bioscience and its competitors. TFBS Bioscience's current Asset Turnover is 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.15, compared to a current price of NT$20.70 — trading 35.6% below its estimated fair value. The current Asset Turnover is 0.07. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Asset Turnover is 0.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?

Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued. The current stock price of NT$20.70 is trading 35.6% below its estimated GF Value™ of NT$32.15. GuruFocus considers TFBS Bioscience to be Possible Value Trap.

Key valuation signals for ROCO:6939:

  • Asset Turnover: 0.07
  • GF Value™: NT$32.15 vs. price of NT$20.70 (35.6% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TFBS Bioscience Business Description

Address No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score

Get the complete analysis for ROCO:6939

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.70
Price
NT$32.15
GF Value